We are live on ! Find out more
LBPH

Longboard Pharmaceuticals, Inc. Common Stock
LBPH

Delisted

LBPH was delisted on the 29th of November, 2024.

Back to rankings

0 hedge funds and large institutions have $0 invested in Longboard Pharmaceuticals, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 124 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 125 → 0 (-125)

100% less funds holding in top 10

Funds holding in top 10: 4 → 0 (-4)

100% less capital invested

Capital invested by funds: $1.33B → $0 (-$1.33B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 124

Holders
–
Holders Change
-125
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
124
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$145M
2
FCM
Farallon Capital Management
California
-$105M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$97M
4
BlackRock
BlackRock
New York
-$94.6M
5
CAM
Cormorant Asset Management
Massachusetts
-$93M
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
26
Candriam SCA
Luxembourg
– -$12M -360,789 Closed
CIBC Asset Management
27
CIBC Asset Management
Ontario, Canada
– -$11.4M -343,012 Closed
SCM
28
Soleus Capital Management
Connecticut
– -$10.6M -318,269 Closed
N
29
Nuveen
North Carolina
– -$10.3M -309,118 Closed
BSA
30
Braun Stacey Associates
New York
– -$9.97M -299,156 Closed
Northern Trust
31
Northern Trust
Illinois
– -$9.53M -286,031 Closed
Charles Schwab
32
Charles Schwab
California
– -$8.69M -260,721 Closed
ABG
33
Ally Bridge Group
New York
– -$8.03M -240,892 Closed
TD Asset Management
34
TD Asset Management
Ontario, Canada
– -$6.01M -187,788 Closed
O
35
OrbiMed
New York
– -$5.67M -170,000 Closed
NFGH
36
Nan Fung Group Holdings
Hong Kong
– -$5.35M -160,570 Closed
SCM
37
Silverarc Capital Management
Massachusetts
– -$4.14M -124,353 Closed
PHS
38
PFM Health Sciences
California
– -$3.79M -113,711 Closed
Manulife (Manufacturers Life Insurance)
39
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$3.78M -113,411 Closed
EI
40
EAM Investors
California
– -$3.7M -110,986 Closed
RAM
41
Readystate Asset Management
Illinois
– -$3.58M -107,345 Closed
PIM
42
Platinum Investment Management
Australia
– -$3.46M -103,858 Closed
JP Morgan Chase
43
JP Morgan Chase
New York
– -$3.27M -97,995 Closed
Prudential Financial
44
Prudential Financial
New Jersey
– -$2.71M -81,210 Closed
Bank of New York Mellon
45
Bank of New York Mellon
New York
– -$2.48M -74,377 Closed
VOYA Investment Management
46
VOYA Investment Management
Georgia
– -$2.38M -71,316 Closed
Deutsche Bank
47
Deutsche Bank
Germany
– -$2.27M -68,252 Closed
Swiss National Bank
48
Swiss National Bank
Switzerland
– -$2.15M -64,500 Closed
Barclays
49
Barclays
United Kingdom
– -$2.06M -61,806 Closed
DC
50
Decheng Capital
California
– -$1.88M -56,350 Closed
1
2
3 4 5

LBPH Hedge Fund Activity: Q4 2024 in Review

0 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Longboard Pharmaceuticals, Inc. Common Stock (LBPH) for Q4 2024, worth a combined $0 — down 100% from $1.33B a quarter earlier.

Sellers outnumbered buyers: 124 funds closed out of LBPH and 0 opened new positions — a net loss of 124 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Fidelity Investments, exiting entirely with an estimated $145M sold.

  • 0 institutional investors held Longboard Pharmaceuticals, Inc. Common Stock (LBPH) as of Q4 2024, down from 125 in Q3 2024.
  • Funds reported $0 of Longboard Pharmaceuticals, Inc. Common Stock stock for Q4 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Longboard Pharmaceuticals, Inc. Common Stock positions in Q4 2024 and 124 closed out, a net change of -124 holders.
  • The largest Longboard Pharmaceuticals, Inc. Common Stock seller in Q4 2024 was Fidelity Investments, an estimated $145M sold.

Based on aggregated 13F filings for Q4 2024.